Case Report: Successful management of psychogenic non-epileptic seizures with intranasal esketamine.
Frontiers in psychiatry January 1, 2025 Muneeb Hashmi, Padmasini Mugunthan, Priyal Jain et al. 2 citations
A patient with treatment-resistant depression and psychogenic non-epileptic seizures (functional seizures) experienced resolution of both conditions after receiving esketamine, a drug approved for treatment-resistant depression and major depressive disorder with suicidal thoughts. The report discusses the potential therapeutic effects of esketamine on functional seizures beyond its antidepressant properties.